Stimulus-cleavable chemistry in the field of controlled drug delivery

Y Xue, H Bai, B Peng, B Fang, J Baell, L Li… - Chemical Society …, 2021 - pubs.rsc.org
Stimulus-cleavable nanoscale drug delivery systems are receiving significant attention
owing to their capability of achieving exquisite control over drug release via the exposure to …

Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease

Q Li, H Yang, Y Chen, H Sun - European journal of medicinal chemistry, 2017 - Elsevier
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders with
notable factor of dysfunction in cholinergic system. Low ACh level can be observed in the …

Prodrugs: design and clinical applications

J Rautio, H Kumpulainen, T Heimbach… - Nature reviews Drug …, 2008 - nature.com
Prodrugs are bioreversible derivatives of drug molecules that undergo an enzymatic and/or
chemical transformation in vivo to release the active parent drug, which can then exert the …

The growing concern of chlorpyrifos exposures on human and environmental health

NK Nandi, A Vyas, MJ Akhtar, B Kumar - Pesticide biochemistry and …, 2022 - Elsevier
Chlorpyrifos (CP) and its highly electrophilic intermediates are principal toxic metabolites.
The active form of CP ie chlorpyrifos oxon (CP-oxon) is responsible for both the insecticidal …

Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs)

CE Wheelock, BM Phillips, BS Anderson… - Reviews of …, 2008 - Springer
The purpose of this review is to examine uses of carboxylesterase activity in environmental
monitoring with a specific emphasis on pyrethroid insecticides. The chapter begins with an …

Nanomedicine from amphiphilized prodrugs: Concept and clinical translation

J Xiang, X Liu, G Yuan, R Zhang, Q Zhou, T Xie… - Advanced drug delivery …, 2021 - Elsevier
Nanomedicines generally consisting of carrier materials with small fractions of active
pharmaceutical ingredients (API) have long been used to improve the pharmacokinetics and …

Drug and pro-drug substrates and pseudo-substrates of human butyrylcholinesterase

P Masson, Z Shaihutdinova, O Lockridge - Biochemical Pharmacology, 2023 - Elsevier
Butyrylcholinesterase (BChE) is present in plasma and numerous cells and organs. Its
physiological function (s) is (are) still unclear. However, this enzyme is of pharmacological …

[HTML][HTML] Enzyme-mediated hydrolytic activation of prodrugs

Y Yang, H Aloysius, D Inoyama, Y Chen… - Acta Pharmaceutica Sinica …, 2011 - Elsevier
Prodrug design is an important part of drug discovery. Prodrugs can offer many advantages
over parent drugs such as increased solubility, enhanced stability, improved bioavailability …

Prodrugs of triterpenoids and their derivatives

M Zhou, RH Zhang, M Wang, GB Xu, SG Liao - European Journal of …, 2017 - Elsevier
Triterpenoids are structurally diverse organic compounds that exist widely as natural
products. Triterpenoids and their derivatives possess a wide range of biological effects …

Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases

JA Crow, A Borazjani, PM Potter, MK Ross - Toxicology and applied …, 2007 - Elsevier
Hydrolytic metabolism of pyrethroid insecticides in humans is one of the major catabolic
pathways that clear these compounds from the body. Rodent models are often used to …